A

Atreca Inc
OTC:BCEL

Watchlist Manager
Atreca Inc
OTC:BCEL
Watchlist
Price: 0.09 USD 4.65% Market Closed
Market Cap: 3.6m USD

Wall Street
Price Targets

BCEL Price Targets Summary
Atreca Inc

There are no price targets for BCEL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Atreca Inc Competitors:
Price Targets
VNDA
Vanda Pharmaceuticals Inc
70% Upside
STOK
Stoke Therapeutics Inc
3% Upside
NBIX
Neurocrine Biosciences Inc
25% Upside
NTLA
Intellia Therapeutics Inc
134% Upside
CCCC
C4 Therapeutics Inc
436% Upside
QTTB
Homology Medicines Inc
261% Upside
GNS
Genus PLC
15% Upside
CMPX
Compass Therapeutics Inc.
143% Upside

Revenue
Forecast

Revenue Estimate
Atreca Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Atreca Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Atreca Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCEL's stock price target?
Not Available

BCEL doesn't have any price targets made by Wall Street professionals.

Back to Top